These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21664941)

  • 1. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
    Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
    Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B and HLA-C Supratyping by Pyrosequencing®.
    Vanni I; Ugolotti E; Larghero P; Biassoni R
    Methods Mol Biol; 2015; 1315():133-51. PubMed ID: 26103897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved method for HLA-B and -C supratyping.
    Biassoni R; Malnati S; Vanni I; Raso A; Sironi F; Broccolo F; Garbarino L; Mazzocco M; Montera M; Larghero P; Di Marco E; Ugolotti E
    J Immunol Methods; 2015 Nov; 426():29-34. PubMed ID: 26232127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK-KIR ligand identification: a quick Q-PCR approach for HLA-C epitope typing.
    Schellekens J; Rozemuller EH; Borst HP; Otten HG; van den Tweel JG; Tilanus MG
    Tissue Antigens; 2007 Apr; 69(4):334-7. PubMed ID: 17389017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.
    Ashouri E; Norman PJ; Guethlein LA; Han AS; Nemat-Gorgani N; Norberg SJ; Ghaderi A; Parham P
    HLA; 2016 Sep; 88(3):87-99. PubMed ID: 27558013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
    López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
    Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.
    López-Vázquez A; Miña-Blanco A; Martínez-Borra J; Njobvu PD; Suárez-Alvarez B; Blanco-Gelaz MA; González S; Rodrigo L; López-Larrea C
    Hum Immunol; 2005 Mar; 66(3):285-9. PubMed ID: 15784466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.
    Boulet S; Kleyman M; Kim JY; Kamya P; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
    AIDS; 2008 Jul; 22(12):1487-91. PubMed ID: 18614872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II DRB high resolution genotyping by pyrosequencing: comparison of group specific PCR and pyrosequencing primers.
    Ringquist S; Alexander AM; Styche A; Pecoraro C; Rudert WA; Trucco M
    Hum Immunol; 2004 Feb; 65(2):163-74. PubMed ID: 14969771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients.
    Cosentini E; Gargiulo L; Bruno P; Lastraioli S; Risitano A; Camerlingo R; Luongo V; Serra M; Sica M; Garzillo C; Giani U; Notaro R; Alfinito F; Ruggiero G; Terrazzano G
    Tissue Antigens; 2012 Oct; 80(4):322-7. PubMed ID: 22803950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
    Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
    Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
    Flores-Villanueva PO; Yunis EJ; Delgado JC; Vittinghoff E; Buchbinder S; Leung JY; Uglialoro AM; Clavijo OP; Rosenberg ES; Kalams SA; Braun JD; Boswell SL; Walker BD; Goldfeld AE
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5140-5. PubMed ID: 11309482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP).
    Cao K; Chopek M; Fernández-Viña MA
    Rev Immunogenet; 1999; 1(2):177-208. PubMed ID: 11253946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
    AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.